These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26011062)

  • 1. A binational registry of adults with pulmonary arterial hypertension complicating congenital heart disease.
    Strange G; Rose M; Kermeen F; O'Donnell C; Keogh A; Kotlyar E; Grigg L; Bullock A; Disney P; Dwyer N; Whitford H; Tanous D; Frampton C; Weintraub R; Celermajer DS
    Intern Med J; 2015 Sep; 45(9):944-50. PubMed ID: 26011062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
    Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
    Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease.
    Thomas IC; Glassner-Kolmin C; Gomberg-Maitland M
    Int J Cardiol; 2013 Oct; 168(4):4117-21. PubMed ID: 23890862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
    van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
    Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
    Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
    Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.
    Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification.
    van Riel AC; Schuuring MJ; van Hessen ID; Zwinderman AH; Cozijnsen L; Reichert CL; Hoorntje JC; Wagenaar LJ; Post MC; van Dijk AP; Hoendermis ES; Mulder BJ; Bouma BJ
    Int J Cardiol; 2014 Jun; 174(2):299-305. PubMed ID: 24794056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
    Durongpisitkul K; Jakrapanichakul D; Sompradikul S
    J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.
    Duffels MG; Engelfriet PM; Berger RM; van Loon RL; Hoendermis E; Vriend JW; van der Velde ET; Bresser P; Mulder BJ
    Int J Cardiol; 2007 Aug; 120(2):198-204. PubMed ID: 17182132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
    Monfredi O; Griffiths L; Clarke B; Mahadevan VS
    Am J Cardiol; 2011 Nov; 108(10):1483-8. PubMed ID: 21943933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications.
    Dimopoulos K; Giannakoulas G; Wort SJ; Gatzoulis MA
    Curr Opin Cardiol; 2008 Nov; 23(6):545-54. PubMed ID: 18830068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.
    Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Dijk AP; de Bruin-Bon RH; Zwinderman AH; Mulder BJ; Bouma BJ
    Int J Cardiol; 2015 Feb; 181():270-6. PubMed ID: 25535690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry.
    Alonso-Gonzalez R; Lopez-Guarch CJ; Subirana-Domenech MT; Ruíz JMO; González IO; Cubero JS; Del Cerro MJ; Salvador ML; Subira LD; Gallego P; Escribano-Subias P;
    Int J Cardiol; 2015 Apr; 184():717-723. PubMed ID: 25781723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult congenital heart disease and pulmonary arterial hypertension: the Texas Adult Congenital Heart Program experience.
    Franklin WJ; Parekh DR; Safdar Z
    Postgrad Med; 2011 Nov; 123(6):32-45. PubMed ID: 22104452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease.
    Schuuring MJ; Bouma BJ; Cordina R; Gatzoulis MA; Budts W; Mullen MP; Vis JC; Celermajer D; Mulder BJ
    Int J Cardiol; 2013 Mar; 164(1):106-10. PubMed ID: 21763017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
    Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
    Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.